Study finds low regret after youth transition
Archived — this story has rotated out of today’s deck. It is kept here in full.
The gist
A peer-reviewed study of nearly 400 people who began gender-affirming hormone therapy as youth found 96.8% said it was the right decision.
The findings land as 27 U.S. states have banned such care for minors.
Background
JAMA Pediatrics is the peer-reviewed medical journal that published the study on 9 November 2026. The cohort study, titled "Satisfaction, Regret, and Harm After Hormone Therapy in Youth From a Multidisciplinary Gender Clinic," analyzed self-reported surveys collected between 2023 and 2025 from nearly 400 people who started gender-affirming hormone therapy as youth. It arrives as gender-affirming care bans for minors have passed into law in 27 U.S. states, and the study's authors said concerns about potential regret and harm have led to widespread efforts to prevent minors from accessing hormone therapy despite standards of care continuing to support its use.
How it unfolded
- Oct 2024A separate JAMA Pediatrics study similarly found very low regret among young people who accessed puberty blockers and/or hormones.
- Nov 9, 2026The peer-reviewed cohort study was published in JAMA Pediatrics, analyzing surveys from nearly 400 people who started gender-affirming hormone therapy as youth, collected between 2023 and 2025.
- Nov 9, 2026The study reported that 96.8% of participants said receiving hormone therapy was the right decision, 2.7% reported some regret, and 1.9% reported feeling harmed.
- Nov 9, 2026Of 372 participants, nine disagreed that it was the right decision; three said they had not been able to make an informed choice, four cited adverse side effects, and six said they no longer desired the secondary sex characteristics HRT induced.
- Nov 9, 2026Respondents had been taking hormone therapy from one month to over 10 years, with an average of around 5 years. Regret was higher among people not currently on hormone therapy and among nonbinary participants than binary trans participants, though still low overall.
- Nov 11, 2026Advocate.com and LGBTQ Nation reported on the study; LGBTQ Nation described it as the largest so far examining satisfaction and regret in people who transitioned before adulthood.
- Nov 12, 2026PinkNews reported the study's findings, including that 96.8% said it was the right decision.
Key terms
- JAMA Pediatrics
- A monthly peer-reviewed medical journal published by the American Medical Association covering all aspects of pediatrics.
- gender-affirming care
- Medical care that helps a transgender person align with their desired gender identity, a major part of transgender health care.
- hormone therapy
- Treatment that administers sex hormones and related medications to align a person's secondary sex characteristics with their gender identity.
Source: Wikipedia
Who’s saying what
- Authors
- The study's authors said overall decisional regret was very low, that the results provide further support for existing standards of care and do not support efforts to categorically restrict or ban access to hormone therapy for trans and gender diverse youth.
- Expert
- Scott Leibowitz, a child and adolescent psychiatrist and WPATH board member, said the study adds to the growing evidence base that individualised gender-affirming care can be beneficial for a young person.
- Support
- Advocate.com said the findings negate the conservative argument that transition is a phase most young people will come to regret and contradict the central argument used to justify bans on gender-affirming care for minors in 27 U.S. states.